Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2002
11/26/2002US6486173 Serotonin-7 (5-ht7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/26/2002US6486165 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/26/2002US6486153 Phenylindole derivatives as 5-HT2A receptor ligands
11/26/2002CA2222312C Dye compositions for keratinic fibres containing n-subsituted 4-hydroxyindole derivatives, new derivatives, method for synthesis, their use in dyeing, and dyeing method
11/21/2002WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002WO2002092565A2 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
11/21/2002WO2002092564A2 Synthesis of cyclopentadiene derivatives
11/21/2002WO2002092078A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
11/21/2002WO2002074309A3 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
11/21/2002WO2002066426A3 Fluoro oxindole derivatives as modulators of kcnq potassium channels
11/21/2002WO2002062290A3 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
11/21/2002WO2002060340A9 Method for identifying maxi-k channel blockers
11/21/2002US20020173659 Indole derivatives for the treatment of osteoporosis
11/21/2002US20020173531 Central nervous system disorders; psychological disorders
11/21/2002US20020173529 Fungicide active substance combinations
11/21/2002US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002US20020173518 Anticoagulant in mammls
11/21/2002US20020173495 Selective androgen receptor modulators and methods of use thereof
11/21/2002US20020173494 Ammonium salts of inositol hexaphosphate, and uses thereof
11/21/2002US20020172885 For increasing sensitivity of photoresist useful for microfabrication of integrated circuits utilizing deep ultraviolet rays (from excimer lasers) and x-rays; resolution; profile
11/21/2002CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002CA2447005A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
11/20/2002EP1258252A1 Integrin expression inhibitors
11/20/2002EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002EP1042285A4 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS
11/20/2002EP0925302B1 Palladium catalyzed indolization
11/20/2002EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/20/2002CN1380880A Process for producing substituted aromatic compound
11/20/2002CN1380838A Method of separating imide compound
11/20/2002CN1380287A 2-acryl-3-substituted indoacetamide derivative and its medical application
11/19/2002US6482957 Useful as an intermediate of a carbocyclic nucleoside anti-viral agent; reacting 2-azabicyclo(2.2.1)hept-5-en-3-one with a sulfonyl halide or phosphoryl halide and then with a nucleic acid base
11/19/2002US6482951 Isoindolin-1-one glucokinase activators
11/19/2002US6482860 Pentafluorobenzenesulfonamides and analogs
11/19/2002US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002US6482846 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/19/2002US6482835 Such as (r)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis
11/19/2002US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002CA2115143C Macromonomers having reactive end groups
11/14/2002WO2002090347A1 Amide compounds
11/14/2002WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090327A1 Piperazinyl-isatins
11/14/2002WO2002090319A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
11/14/2002WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090313A1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
11/14/2002WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002WO2002074764A3 Piperazine derivatives and their use as 5-ht1b ligands
11/14/2002WO2002060339A3 Ophthalmic compositions for treating ocular hypertension
11/14/2002WO2001097787A3 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
11/14/2002WO2001020995A9 Compounds directed against pilus biogenesis and activity in pathogenic bacteria; methods and compositions for synthesis thereof
11/14/2002US20020169331 Method of separating imide compound
11/14/2002US20020169326 Fatty acid derivatives
11/14/2002US20020169322 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
11/14/2002US20020169200 Antitumor, antiinflammatory and antiarthritic agents, treating metastasis, restenosis, osteoporosis, inflammation, macular degeneration, and diabetic retinopathy
11/14/2002US20020169198 Agonists of the progesterone receptor; contraceptives, hormone replacement therapy and treating menopause symptoms
11/14/2002US20020169164 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
11/14/2002US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002US20020166180 For oxidative coloring agent for keratin fibers
11/14/2002CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/13/2002EP1256576A1 Fused imidazolium derivatives
11/13/2002EP1256574A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
11/13/2002EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/13/2002EP1255752A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
11/13/2002EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors
11/13/2002EP1255536A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
11/13/2002EP1112272B1 Muscarinic agonists and antagonists
11/13/2002EP1068199B1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
11/13/2002EP0843672B1 One pot synthesis of 2-oxazolidinone derivatives
11/13/2002EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002CN1379774A Compounds
11/13/2002CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002CN1379761A Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands
11/13/2002CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives
11/13/2002CN1379024A Process for preparing 5-phenylformyl-3-methyl-2-indolone
11/12/2002US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002US6479534 Indoline derivatives and method of treating obesity
11/12/2002US6479528 Methods for inhibiting or reversing tau filament formation polymerization
11/12/2002US6479524 To prolong the thrombin time
11/12/2002US6479503 Cycloalkano-indole and -azaindole derivatives
11/12/2002US6479480 1h-indole derivatives bearing an optionally substituted phenyl moiety at the 2-position of the indole ring system and a methylene-linked heterocyclic moiety at the 3-position of the indole ring system; schizophrenia treatment
11/12/2002US6479123 Dipyrromethene-metal chelate compound and optical recording medium using thereof
11/12/2002CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/07/2002WO2002088274A1 Double-spiro organic compounds and electroluminescent devices
11/07/2002WO2002088114A2 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
11/07/2002WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002WO2002088083A1 Process for producing tetrahydrocarbazole derivative
11/07/2002WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002WO2001085687A1 Substituted indoles as parp inhibitors
11/07/2002US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002US20020165402 Quarternary ammonium compounds
11/07/2002US20020165398 Amino-thiophene-amido derivatives
11/07/2002US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002US20020165343 Growth hormone secretagogues
11/07/2002US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use